Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.46 | -$0.01 | -$0.19 |
Q2 2024 | 1 | -$0.52 | -$0.01 | -$0.21 |
Q3 2024 | 2 | -$0.71 | -$0.02 | -$0.28 |
Q4 2024 | 6 | -$0.38 | $0.10 | -$0.17 |
Q1 2025 | 5 | -$0.43 | -$0.24 | -$0.30 |
Q2 2025 | 2 | -$0.69 | -$0.02 | -$0.28 |
Q3 2025 | 2 | -$0.64 | -$0.02 | -$0.26 |
Q4 2025 | 2 | -$0.73 | -$0.02 | -$0.29 |
Wave Life Sciences Ltd. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.25 earnings per share for the quarter, missing analysts' consensus estimates of $-0.16 by $0.09. The company had revenue of -7,676,000 for the quarter and had revenue of 113.31 M for the year. Wave Life Sciences Ltd. has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -11.99. Wave Life Sciences Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/30/2024 | Q3 2024 | -$0.47 | $16.61 M | $-7,676,000 | ||
08/08/2024 | Q2 2024 | -$0.16 | -$0.25 | -0.09 | $19.45 M | $19.69 M |
05/10/2024 | Q1 2024 | -$0.24 | $12.54 M | |||
03/06/2024 | Q4 2023 | -$0.19 | -$0.15 | 0.04 | $29.06 M | |
11/09/2023 | Q3 2023 | -$0.18 | $0.07 | 0.25 | $23.43 M | $49.21 M |
08/03/2023 | Q2 2023 | -$0.32 | -$0.20 | 0.12 | $7.94 M | $22.11 M |
05/03/2023 | Q1 2023 | $0.06 | -$0.24 | -0.3 | $12.93 M | |
05/05/2023 | Q4 2022 | -$0.47 | $1.24 M | |||
11/10/2022 | Q3 2022 | -$0.48 | -$0.42 | 0.06 | $8.20 M | $285,000 |
08/11/2022 | Q2 2022 | -$0.56 | $0.00 | 0.56 | $3.83 M | $375,000 |
05/12/2022 | Q1 2022 | -$0.56 | -$0.62 | -0.06 | $1.75 M | |
03/03/2022 | Q4 2021 | -$0.47 | -$0.61 | -0.14 | $1.77 M | |
11/10/2021 | Q3 2021 | -$0.64 | -$0.12 | 0.52 | $10.36 M | $36.42 M |
08/05/2021 | Q2 2021 | -$0.61 | -$0.78 | -0.17 | $9.79 M | $2.78 M |
05/13/2021 | Q1 2021 | -$0.56 | -$0.86 | -0.3 | $0 | |
03/04/2021 | Q4 2020 | -$0.55 | -$0.59 | -0.04 | $9.44 M | |
11/09/2020 | Q3 2020 | -$0.73 | -$0.86 | -0.13 | $12.63 M | $3.45 M |
08/10/2020 | Q2 2020 | -$1.03 | -$1.15 | -0.12 | $6.37 M | $3.03 M |
05/11/2020 | Q1 2020 | -$1.34 | -$1.38 | -0.04 | $4.16 M | |
03/02/2020 | Q4 2019 | -$1.48 | -$1.65 | -0.17 | $2.40 M |
Wave Life Sciences Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
The conference call for Wave Life Sciences Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Wave Life Sciences Ltd.'s latest earnings report can be read online.
Wave Life Sciences Ltd. (:WVE) has a recorded annual revenue of $113.31 M.
Wave Life Sciences Ltd. (:WVE) has a recorded net income of $113.31 M. Wave Life Sciences Ltd. has generated $-0.54 earnings per share over the last four quarters.
Wave Life Sciences Ltd. (:WVE) has a price-to-earnings ratio of -11.99 and price/earnings-to-growth ratio is 0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED